$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades. When insiders purchase…
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
Analysts’ ratings for Integra Lifesciences (NASDAQ:IART) over the last quarter vary from bullish to bearish, as provided by…
Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What’s Driving Markets Monday?
The stock market is poised to mark a third consecutive session of gains, with major indices all trading in the green during midday trading in New York on Monday, as traders continue to react positively to quarterly earnings and the Federal Reserve’s unexpectedly dovish stance
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday. Shares of Spirit Airlines,…
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday’s Mid-Day Session
Shares of Perficient, Inc (NASDAQ:PRFT) shares rose sharply during Monday’s session after the company disclosed an acquisition deal…
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 39.5% to $2.93 during Monday’s regular session. The company’s market cap…
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?
Integra LifeSciences surpasses expectations with first-quarter revenues of $368.9 million, reporting growth in Codman Specialty Surgical and updates fiscal year 2024 guidance.
Integra LifeSciences Expects Q2 Revenue of $411M-$416M Vs $395.8M Est, Adj EPS of $0.60-$0.65 Vs $0.75 Est
2024 Outlook
For the full year 2024, the Company is updating its revenue and adjusted EPS expectations to $1.672 to $1.687 billion and $3.01 to $3.11, respectively. The revenue
Integra LifeSciences To Spotlight CereLink Intracranial Pressure Monitoring System At The American Association Of Neurological Surgeons Annual Scientific Meeting
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, is pleased to announce that following a successful Q1 2024 U.S. relaunch of its CereLink® ICP Monitoring System,
The Analyst Landscape: 7 Takes On Integra Lifesciences
In the preceding three months, 7 analysts have released ratings for Integra Lifesciences (NASDAQ:IART), presenting a wide array…